These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 19216007)
1. Preparation of spermine conjugates with acidic retinoids with potent ribonuclease P inhibitory activity. Magoulas G; Papaioannou D; Papadimou E; Drainas D Eur J Med Chem; 2009 Jun; 44(6):2689-95. PubMed ID: 19216007 [TBL] [Abstract][Full Text] [Related]
2. Isolation of ribonuclease P activity from human epidermis and its regulation by retinoids in vitro. Pavlidou D; Vourekas A; Monastirli A; Kalavrizioti D; Tsambaos D; Drainas D Acta Derm Venereol; 2006; 86(2):114-8. PubMed ID: 16648912 [TBL] [Abstract][Full Text] [Related]
6. Structure-based optimization of a potent class of arylamide FMS inhibitors. Meegalla SK; Wall MJ; Chen J; Wilson KJ; Ballentine SK; Desjarlais RL; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Illig CR Bioorg Med Chem Lett; 2008 Jun; 18(12):3632-7. PubMed ID: 18495479 [TBL] [Abstract][Full Text] [Related]
7. Partial purification and characterization of RNase P from human peripheral lymphocytes. Vourekas A; Vryzaki E; Toumpeki C; Stamatopoulou V; Monastirli A; Tsambaos D; Drainas D Exp Dermatol; 2009 Feb; 18(2):130-3. PubMed ID: 18637127 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases. Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940 [TBL] [Abstract][Full Text] [Related]
9. Chlorogenic acid derivatives with alkyl chains of different lengths and orientations: potent alpha-glucosidase inhibitors. Ma CM; Hattori M; Daneshtalab M; Wang L J Med Chem; 2008 Oct; 51(19):6188-94. PubMed ID: 18783210 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate. Beck J; Vercheval L; Bebrone C; Herteg-Fernea A; Lassaux P; Marchand-Brynaert J Bioorg Med Chem Lett; 2009 Jul; 19(13):3593-7. PubMed ID: 19467869 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effects in gene delivery-a structure-activity approach to the optimisation of hybrid dendritic-lipidic transfection agents. Jones SP; Gabrielson NP; Pack DW; Smith DK Chem Commun (Camb); 2008 Oct; (39):4700-2. PubMed ID: 18830464 [TBL] [Abstract][Full Text] [Related]
17. Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates. Berchanski A; Lapidot A Bioconjug Chem; 2008 Sep; 19(9):1896-906. PubMed ID: 18712898 [TBL] [Abstract][Full Text] [Related]
18. MMT, Npeoc-protected spermine, a valuable synthon for the solid phase synthesis of oligonucleotide oligospermine conjugates via guanidine linkers. Perche P; Kotera M; Remy JS Bioorg Med Chem; 2011 Mar; 19(6):1972-7. PubMed ID: 21339069 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates. Zhu Y; Zhao X; Zhu X; Wu G; Li Y; Ma Y; Yuan Y; Yang J; Hu Y; Ai L; Gao Q J Med Chem; 2009 Jul; 52(14):4192-9. PubMed ID: 19537716 [TBL] [Abstract][Full Text] [Related]
20. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]